ulie Young and Carol Keohane of Olympus and Steve Emerson are participating in Q1’s 12th Annual Medical Device & Diagnostic Sales Training & Development Conference on February 26-27 in Charlotte, NC.

Most Common Symbols and What They Mean

Considerations while Navigating Regulatory Pathways for Novel IVD Tests, Companion Diagnostics, & Precision Medicine, Addressing Clinical Trial Design & Validation of Technological Advancements, with Insights on Challenging International Regulations including EU IVDR & Asian Regulatory Pathways
October 22-23, 2019 | Alexandria, VA | Hilton Alexandria Old Town

Practical Interpretation of Increasingly Differing Payer Requirements & Efficiently Reflecting Expectations in Clinical Strategies, Overcoming Challenges in Ensuring Maximum Reimbursement for Established & Novel Tests with the Ongoing Impact of PAMA & Fluctuating Diagnostic Rates, in addition to Grey Areas in Prior Authorization Processes
December 3-4, 2019 | Boston, MA

Ensuring QMS Preparedness in Light of the MDR & IVDR with a Focus on Economic Operator Compliance, Enhanced Supplier Control & Optimal Design of a Robust PMS Strategy, Successfully Managing International Audit Readiness, all while Digitalizing QMS Processes & Data
December 4-5, 2019 | Frankfurt, Germany

Clarification of Regulatory Requirements for Companion Diagnostics and NGS, Insight into the Status of Laboratory Developed Test Specific Policies, all while Strategizing to Ensure Compliance with New European and Asian Market Rules
December 12-13, 2019 | San Diego, CA

Aligning Regulatory Data and Information through Enhanced Integration & Utilization of Regulatory Information Management Systems which Support the Highest Levels of Data Integrity and Seamlessly Support Global Regulatory Documentation from throughout the Product Lifecycle
January 14-15, 2020 | Arlington, VA